Polycystic Kidney Disease (PKD) Causes, Symptoms, and Treatment

Polycystic Kidney Disease (PKD) is a genetic condition in which many cysts form in the kidneys, eventually affecting the ability of the kidneys to function. Depending on the type of PKD, symptoms often begin either in early adulthood, between the ages of 30~40 years, or in infancy or early childhood. Both men and women of all races are likely to be affected equally.

Causes

PKD is an inherit disease, which includes two types, called Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Autosomal Recessive Polycystic Kidney Disease (ARPKD).
90% of patients belong to ADPKD, or adult PKD, and it occurs when one parent has passed the gene on to a child. The gene is dominant, and there is a 50% chance that a child will get PKD if one parent has this disorder. However, in some cases the disease may occur spontaneously due to a new genetic mutation other than inherited from parents.
10% of patients (mainly infants and children) suffer from the rarer ARPKD, and it happens when the parents carry the gene but are not affected by PKD. There is a 25% chance that a child born to parents that are both carriers will get the disease. If only one parent carries the gene, children will not be affected.

Symptoms

● Back or side pain
● Tenderness around the abdomen
● Hematuria
● Hypertension
● Urinary tract infection

Treatment

The traditional treatments for PKD include medications, surgery (remove the cysts), dialysis and kidney transplant. Immunotherapy available for PKD may consists some of:

● Brand new medications
● Micro-Chinese Medicine Osmotherapy
● Immunotherapy
● Immune clearance: immunosorption, plasmapheresis and blood purification
Features
● No toxin or side effects to human body.
● Help patients avoid the surgery and control the progression of PKD.
● Help patients in the early stage avoid dialysis. Prolong the interval of dialysis for those in advanced stage.
● Significantly extends survival time with a good quality of life.